13D/13G Filings - Point72 Asset Management, L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, 2, 3, 4, 5, 6, ...17, 18, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-05-21
4:56 pm
Purchase
2024-05-20 13G Rapid7, Inc.
RPD
Point72 Asset Management, L.P. 3,121,415
5.000%
1,243,804increase
(+66.24%)
Filing
History
2024-05-09
5:29 pm
Purchase
2024-05-02 13G Corvus Pharmaceuticals, Inc.
CRVS
Point72 Asset Management, L.P. 17,050,384
9.900%
17,050,384increase
(New Position)
Filing
History
2024-04-26
4:15 pm
Purchase
2024-04-25 13G Avid Bioservices, Inc.
CDMO
Point72 Asset Management, L.P. 3,226,006
5.100%
3,226,006increase
(New Position)
Filing
History
2024-04-05
4:05 pm
Purchase
2024-04-04 13G Sutro Biopharma, Inc.
STRO
Point72 Asset Management, L.P. 5,932,908
7.900%
5,932,908increase
(New Position)
Filing
History
2024-03-26
4:21 pm
Purchase
2024-03-25 13G Fox Corporation
FOXA
Point72 Asset Management, L.P. 12,046,118
5.000%
12,046,118increase
(New Position)
Filing
History
2024-03-25
4:33 pm
Purchase
2024-03-21 13G LENZ Therapeutics, Inc.
LENZ
Point72 Asset Management, L.P. 1,882,693
7.400%
1,882,693increase
(New Position)
Filing
History
2024-03-07
4:15 pm
Purchase
2024-03-06 13G Terns Pharmaceuticals, Inc.
TERN
Point72 Asset Management, L.P. 3,921,226
6.300%
3,921,226increase
(New Position)
Filing
History
2024-02-29
4:31 pm
Purchase
2024-02-28 13G Pulmonx Corporation
LUNG
Point72 Asset Management, L.P. 1,936,083
5.000%
389,994increase
(+25.22%)
Filing
History
2024-02-27
4:14 pm
Purchase
2024-02-26 13G Liberty Live Group
LLYVA
Point72 Asset Management, L.P. 1,287,149
5.000%
1,287,149increase
(New Position)
Filing
History
2024-02-23
4:28 pm
Purchase
2024-02-22 13G Ventyx Biosciences, Inc.
VTYX
Point72 Asset Management, L.P. 3,017,093
5.100%
3,017,093increase
(New Position)
Filing
History
2024-02-23
4:15 pm
Purchase
2024-02-22 13G Caribou Biosciences, Inc.
CRBU
Point72 Asset Management, L.P. 4,432,602
5.000%
435,057increase
(+10.88%)
Filing
History
2024-02-21
4:16 pm
Purchase
2024-02-20 13G Agenus Inc.
AGEN
Point72 Asset Management, L.P. 1,413,425
6.800%
1,413,368increase
(+2492389.95%)
Filing
History
2024-02-14
4:20 pm
Purchase
2023-12-31 13G Abeona Therapeutics Inc.
ABEO
Point72 Asset Management, L.P. 1,649,740
6.400%
499,092increase
(+43.37%)
Filing
History
2024-02-14
4:19 pm
Purchase
2023-12-31 13G PagSeguro Digital Ltd.
PAGS
Point72 Asset Management, L.P. 10,933,610
5.600%
231,012increase
(+2.16%)
Filing
History
2024-02-14
4:18 pm
Purchase
2023-12-31 13G Lyra Therapeutics, Inc.
LYRA
Point72 Asset Management, L.P. 3,030,283
5.800%
30,283increase
(+1.01%)
Filing
History
2024-02-14
4:17 pm
Sale
2023-12-31 13G Celldex Therapeutics, Inc.
CLDX
Point72 Asset Management, L.P. 2,756,122
5.000%
-866,014decrease
(-23.91%)
Filing
History
2024-02-14
4:17 pm
Sale
2023-12-31 13G Madison Square Garden Entertainment Corp.
MSGE
Point72 Asset Management, L.P. 2,299,168
5.600%
-4,445decrease
(-0.19%)
Filing
History
2024-02-14
4:16 pm
Purchase
2023-12-31 13G TPI Composites, Inc.
TPIC
Point72 Asset Management, L.P. 3,286,322
7.100%
1,154,151increase
(+54.13%)
Filing
History
2024-02-14
4:15 pm
Purchase
2023-12-31 13G Morphic Holding, Inc.
MORF
Point72 Asset Management, L.P. 4,591,000
9.200%
2,086,617increase
(+83.32%)
Filing
History
2024-02-14
4:14 pm
Sale
2023-12-31 13G Crinetics Pharmaceuticals, Inc.
CRNX
Point72 Asset Management, L.P. 3,416,900
5.100%
-311,052decrease
(-8.34%)
Filing
History
Goto Prev, 0, 1, 2, 3, 4, 5, 6, ...17, 18, Next